Vyvanse 10 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FS6RM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,052
Award facts
- Contract value 100% obligated
- $16,052.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Vyvanse 10 mg capsules (100-count units) with a ceiling value of $16,052.40. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents a single fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is classified as a child award, leveraging the company's broader pharmaceutical supply agreement designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen's corporate office, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company's DLA contract vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. This specific delivery order for Vyvanse—a treatment for attention deficit hyperactivity disorder—exemplifies the company's role in providing essential medications across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FS6RM?
SPE2DB25FS6RM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FS6RM worth?
The government has obligated $16,052 on SPE2DB25FS6RM.
Is contract SPE2DB25FS6RM an order under another contract?
Yes. SPE2DB25FS6RM is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6RM competed?
The extent of competition for SPE2DB25FS6RM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award